Bulletin du cancer
[Vorasidenib as monotherapy in grade 2 astrocytoma or oligodendroglioma with an IDH1 R132 or IDH2 R172 mutation].
Jean Levasseur, Emeline Tabouret
Published: 202510.1016/j.bulcan.2025.10.003
No abstract available for this study.
Jean Levasseur, Emeline Tabouret
No abstract available for this study.